Depolarization selectively increases the expression of the Kv3.1 potassium channel in developing inferior colliculus neurons.
The Kv3.1 channel subunit, when expressed heterologously, gives rise to a high-threshold noninactivating potassium current. Experiments with auditory neurons have suggested that the presence of this channel subunit enables them to fire action potentials at high frequencies. We have found that the expression levels of Kv3.1 transcripts increase in inferior colliculus neurons before the onset of hearing and then remain relatively constant. Because spontaneous neuronal activity plays an important role in modulating neuronal excitability during development, we examined the effects of depolarization with an elevated concentration of external potassium ions on the expression of Kv3.1 channel subunits in immature inferior colliculus neurons. Elevated potassium produced a marked increase in Kv3.1 mRNA levels and in the amplitude of a high-threshold, noninactivating current before the onset of hearing. This increase was prevented by the presence of a calcium channel blocker, indicating that calcium influx mediated the depolarization-induced increase in this current. In contrast, treatment with an elevated external potassium concentration caused only a moderate increase in the peak amplitude of a lower-threshold inactivating current. The repolarization of action potentials in the high-potassium-treated cells was more rapid and complete than in the control cells. Computer simulations confirmed that this change could be explained by a change in Kv3.1-like current of the same magnitude as recorded in voltage-clamp experiments. Thus, depolarization and calcium influx may alter the excitability of immature inferior colliculus neurons by selectively increasing the levels of a Kv3. 1-like potassium current.
Liu
S Q
SQ
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520-8066, USA.
Kaczmarek
L K
LK
D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D002118:Calcium / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D066298:In Vitro Techniques; D007245:Inferior Colliculi / Q000378:metabolism*; D008564:Membrane Potentials / Q000187:drug effects; D009479:Neuropeptides / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D011188:Potassium / Q000494:pharmacology; D015221:Potassium Channels / Q000378:metabolism*; D024642:Potassium Channels, Voltage-Gated; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D051670:Shaw Potassium Channels
D009479:Neuropeptides; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D012333:RNA, Messenger; D051670:Shaw Potassium Channels; D011188:Potassium; D002118:Calcium